CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 58 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2022. The put-call ratio across all filers is 2.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $663,935 | -27.1% | 763,232 | -6.2% | 0.00% | – |
| Q2 2023 | $910,907 | +9.7% | 813,310 | +1.9% | 0.00% | – |
| Q1 2023 | $830,462 | -7.2% | 798,521 | -0.1% | 0.00% | – |
| Q4 2022 | $895,106 | -33.4% | 799,201 | -32.8% | 0.00% | – |
| Q3 2022 | $1,345,000 | -24.6% | 1,189,949 | -1.9% | 0.00% | – |
| Q2 2022 | $1,783,000 | -36.1% | 1,212,993 | -0.5% | 0.00% | – |
| Q1 2022 | $2,792,000 | -16.7% | 1,219,167 | -0.0% | 0.00% | – |
| Q4 2021 | $3,353,000 | -30.5% | 1,219,389 | +51.6% | 0.00% | – |
| Q3 2021 | $4,826,000 | +28.5% | 804,352 | +4.3% | 0.00% | – |
| Q2 2021 | $3,757,000 | +74.2% | 771,558 | -11.6% | 0.00% | – |
| Q1 2021 | $2,157,000 | +2.9% | 873,110 | +14.1% | 0.00% | – |
| Q4 2020 | $2,097,000 | +80.3% | 765,166 | +1.3% | 0.00% | – |
| Q3 2020 | $1,163,000 | -18.2% | 755,093 | -0.1% | 0.00% | – |
| Q2 2020 | $1,421,000 | +10.2% | 756,187 | -0.2% | 0.00% | – |
| Q1 2020 | $1,289,000 | -40.7% | 757,602 | +1.0% | 0.00% | – |
| Q4 2019 | $2,175,000 | +504.2% | 749,953 | +31.4% | 0.00% | – |
| Q3 2019 | $360,000 | -35.7% | 570,889 | -0.9% | 0.00% | – |
| Q2 2019 | $560,000 | -78.0% | 576,103 | -68.8% | 0.00% | – |
| Q1 2019 | $2,551,000 | +25.3% | 1,847,509 | -2.9% | 0.00% | – |
| Q4 2018 | $2,036,000 | -82.6% | 1,902,788 | -0.0% | 0.00% | -100.0% |
| Q3 2018 | $11,704,000 | -41.1% | 1,903,108 | +2.3% | 0.00% | 0.0% |
| Q2 2018 | $19,883,000 | +52.6% | 1,859,948 | +53.1% | 0.00% | 0.0% |
| Q1 2018 | $13,033,000 | +89.4% | 1,214,656 | +23.6% | 0.00% | – |
| Q4 2017 | $6,882,000 | -42.0% | 983,125 | -27.6% | 0.00% | -100.0% |
| Q3 2017 | $11,875,000 | +0.1% | 1,358,745 | +4.4% | 0.00% | 0.0% |
| Q2 2017 | $11,858,000 | +86.4% | 1,301,647 | +62.4% | 0.00% | – |
| Q1 2017 | $6,363,000 | +35250.0% | 801,413 | +38879.2% | 0.00% | – |
| Q4 2016 | $18,000 | – | 2,056 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 2,467,500 | $14,805,000 | 7.67% |
| ACUTA CAPITAL PARTNERS, LLC | 1,316,268 | $7,898,000 | 2.79% |
| AJU IB Investment Co., Ltd. | 293,555 | $1,761,000 | 1.14% |
| RTW INVESTMENTS, LP | 4,206,765 | $25,241,000 | 0.38% |
| EAM Investors, LLC | 247,561 | $1,485,000 | 0.25% |
| Carmignac Gestion | 2,475,652 | $14,854,000 | 0.18% |
| Curi Wealth Management, LLC | 25,000 | $150,000 | 0.07% |
| CAXTON ASSOCIATES LP | 66,569 | $399,000 | 0.04% |
| Newman Dignan & Sheerar, Inc. | 21,523 | $129,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 316,600 | $1,900,000 | 0.04% |